Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

This study tests a new drug called TQB2934 for people with systemic light chain amyloidosis, a rare disease where abnormal proteins build up in organs. The trial enrolls 70 adults who have already tried standard treatments. The goal is to see if the drug can improve blood markers…

This study tests whether a new drug combination (TQB2868 injection plus anlotinib capsules) with chemotherapy can help people with metastatic pancreatic cancer live longer compared to standard chemotherapy alone. About 566 adults aged 18-75 with stage IV pancreatic cancer will ta…

This study tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps (growths in the nose). The drug blocks a protein involved in inflammation, aiming to shrink polyps and reduce congestion. About 246 adults will receive either the drug or a place…

This early-stage study tests a new drug called TQB2922, given as a shot under the skin, in about 42 people with advanced cancers that have not responded to standard treatments. The main goal is to check the drug's safety and how the body processes it. This is a first step to see …

This study tests an injection called TQH2722 in about 300 adults aged 18-75 with seasonal allergic rhinitis (hay fever). The goal is to see if the drug safely eases symptoms like runny nose, sneezing, and congestion when added to standard allergy treatments. Participants must hav…